RCUS logo

Arcus Biosciences, Inc. (RCUS) Cash From Operations

Annual CFO:

-$170.00M+$136.00M(+44.44%)
December 31, 2024

Summary

  • As of today, RCUS annual cash from operations is -$170.00 million, with the most recent change of +$136.00 million (+44.44%) on December 31, 2024.
  • During the last 3 years, RCUS annual cash from operations has risen by +$86.00 million (+33.59%).
  • RCUS annual cash from operations is now -138.81% below its all-time high of $438.00 million, reached on December 31, 2022.

Performance

RCUS Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRCUScash flow metrics

Quarterly CFO:

-$97.00M+$36.00M(+27.07%)
September 30, 2025

Summary

  • As of today, RCUS quarterly cash from operations is -$97.00 million, with the most recent change of +$36.00 million (+27.07%) on September 30, 2025.
  • Over the past year, RCUS quarterly cash from operations has dropped by -$123.00 million (-473.08%).
  • RCUS quarterly cash from operations is now -114.83% below its all-time high of $654.00 million, reached on March 31, 2022.

Performance

RCUS Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRCUScash flow metrics

TTM CFO:

-$462.00M-$123.00M(-36.28%)
September 30, 2025

Summary

  • As of today, RCUS TTM cash from operations is -$462.00 million, with the most recent change of -$123.00 million (-36.28%) on September 30, 2025.
  • Over the past year, RCUS TTM cash from operations has dropped by -$304.00 million (-192.41%).
  • RCUS TTM cash from operations is now -197.71% below its all-time high of $472.84 million, reached on June 30, 2022.

Performance

RCUS TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRCUScash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

RCUS Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+44.4%-473.1%-192.4%
3Y3 Years+33.6%-19.8%-203.7%
5Y5 Years-131.4%-144.8%-404.8%

RCUS Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-138.8%+44.4%-473.1%+27.1%-203.7%at low
5Y5-Year-138.8%+44.4%-114.8%+27.1%-197.7%at low
All-TimeAll-Time-138.8%+44.4%-114.8%+27.1%-197.7%at low

RCUS Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
-$97.00M(+27.1%)
-$462.00M(-36.3%)
Jun 2025
-
-$133.00M(-0.8%)
-$339.00M(-13.0%)
Mar 2025
-
-$132.00M(-32.0%)
-$300.00M(-76.5%)
Dec 2024
-$170.00M(+44.4%)
-$100.00M(-484.6%)
-$170.00M(-7.6%)
Sep 2024
-
$26.00M(+127.7%)
-$158.00M(+36.0%)
Jun 2024
-
-$94.00M(-4600.0%)
-$247.00M(-17.6%)
Mar 2024
-
-$2.00M(+97.7%)
-$210.00M(+31.4%)
Dec 2023
-$306.00M(-169.9%)
-$88.00M(-39.7%)
-$306.00M(-6.3%)
Sep 2023
-
-$63.00M(-10.5%)
-$287.74M(+5.9%)
Jun 2023
-
-$57.00M(+41.8%)
-$305.70M(+2.6%)
Mar 2023
-
-$98.00M(-40.5%)
-$314.00M(-171.7%)
Dec 2022
$438.00M(+271.1%)
-$69.74M(+13.9%)
$438.00M(-1.7%)
Sep 2022
-
-$80.96M(-24.0%)
$445.64M(-5.8%)
Jun 2022
-
-$65.30M(-110.0%)
$472.84M(+1.9%)
Mar 2022
-
$654.00M(+1153.1%)
$464.15M(+281.2%)
Dec 2021
-$256.00M
-$62.10M(-15.5%)
-$256.17M(-5.0%)
Sep 2021
-
-$53.76M(+27.4%)
-$243.95M(-1035.6%)
Jun 2021
-
-$74.00M(-11.6%)
$26.07M(-65.8%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$66.32M(-33.0%)
$76.13M(-31.5%)
Dec 2020
$111.00M(+251.1%)
-$49.88M(-123.1%)
$111.17M(-26.7%)
Sep 2020
-
$216.26M(+1003.4%)
$151.58M(+264.6%)
Jun 2020
-
-$23.94M(+23.5%)
-$92.08M(-4.8%)
Mar 2020
-
-$31.28M(-230.2%)
-$87.90M(-19.7%)
Dec 2019
-$73.46M(-70.9%)
-$9.47M(+65.4%)
-$73.46M(-3.3%)
Sep 2019
-
-$27.40M(-38.7%)
-$71.10M(-28.2%)
Jun 2019
-
-$19.75M(-17.3%)
-$55.46M(-19.1%)
Mar 2019
-
-$16.84M(-136.9%)
-$46.59M(-8.4%)
Dec 2018
-$43.00M(-71.6%)
-$7.11M(+39.6%)
-$43.00M(+29.5%)
Sep 2018
-
-$11.77M(-8.2%)
-$60.95M(+17.0%)
Jun 2018
-
-$10.88M(+17.9%)
-$73.42M(-5.9%)
Mar 2018
-
-$13.25M(+47.1%)
-$69.36M(-5.6%)
Dec 2017
-$25.06M(-93.6%)
-$25.06M(-3.4%)
-$65.70M(-61.7%)
Sep 2017
-
-$24.23M(-255.6%)
-$40.65M(-147.7%)
Jun 2017
-
-$6.82M(+29.0%)
-$16.41M(-71.0%)
Mar 2017
-
-$9.60M
-$9.60M
Dec 2016
-$12.94M
-
-

FAQ

  • What is Arcus Biosciences, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Arcus Biosciences, Inc.?
  • What is Arcus Biosciences, Inc. annual cash from operations year-on-year change?
  • What is Arcus Biosciences, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Arcus Biosciences, Inc.?
  • What is Arcus Biosciences, Inc. quarterly cash from operations year-on-year change?
  • What is Arcus Biosciences, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Arcus Biosciences, Inc.?
  • What is Arcus Biosciences, Inc. TTM cash from operations year-on-year change?

What is Arcus Biosciences, Inc. annual cash from operations?

The current annual cash from operations of RCUS is -$170.00M

What is the all-time high annual cash from operations for Arcus Biosciences, Inc.?

Arcus Biosciences, Inc. all-time high annual cash from operations is $438.00M

What is Arcus Biosciences, Inc. annual cash from operations year-on-year change?

Over the past year, RCUS annual cash from operations has changed by +$136.00M (+44.44%)

What is Arcus Biosciences, Inc. quarterly cash from operations?

The current quarterly cash from operations of RCUS is -$97.00M

What is the all-time high quarterly cash from operations for Arcus Biosciences, Inc.?

Arcus Biosciences, Inc. all-time high quarterly cash from operations is $654.00M

What is Arcus Biosciences, Inc. quarterly cash from operations year-on-year change?

Over the past year, RCUS quarterly cash from operations has changed by -$123.00M (-473.08%)

What is Arcus Biosciences, Inc. TTM cash from operations?

The current TTM cash from operations of RCUS is -$462.00M

What is the all-time high TTM cash from operations for Arcus Biosciences, Inc.?

Arcus Biosciences, Inc. all-time high TTM cash from operations is $472.84M

What is Arcus Biosciences, Inc. TTM cash from operations year-on-year change?

Over the past year, RCUS TTM cash from operations has changed by -$304.00M (-192.41%)
On this page